{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:34:08Z","timestamp":1781908448274,"version":"3.54.5"},"reference-count":30,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,19]]},"DOI":"10.31744\/einstein_journal\/2019ao4696","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T13:21:56Z","timestamp":1566307316000},"source":"Crossref","is-referenced-by-count":8,"title":["Drug therapy problems for patients with tuberculosis and HIV\/AIDS at a reference hospital"],"prefix":"10.31744","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-1083","authenticated-orcid":false,"given":"Nat\u00e1lia Helena de","family":"Resende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-4472","authenticated-orcid":false,"given":"Silvana Sp\u00edndola de","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4340-0659","authenticated-orcid":false,"given":"Maria das Gra\u00e7as Braga","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2823-6288","authenticated-orcid":false,"given":"Jo\u00e3o Paulo Amaral","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-7338","authenticated-orcid":false,"given":"Adriano Max Moreira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3597-8063","authenticated-orcid":false,"given":"Dirce In\u00eas da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-6352","authenticated-orcid":false,"given":"W\u00e2nia da Silva","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"4","key":"key20190820092154_B1","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/IAI.01126-10","article-title":"HIV-1\/Mycobacterrium tuberculosis co-infection immunology: how does HIV-1 exacerbate Tuberculosis?","volume":"79","author":"Diedrich","year":"2011","unstructured":"1. Diedrich CR, Flynn JL. HIV-1\/Mycobacterrium tuberculosis co-infection immunology: how does HIV-1 exacerbate Tuberculosis? Infect Immun. 2011; 79(4):1407-17. Review.","journal-title":"Infect Immun."},{"key":"key20190820092154_B2","volume-title":"Global Tuberculosis Report 2017","author":"World Health Organization (WHO)","year":"2017","unstructured":"2. World Health Organization (WHO). Global Tuberculosis Report 2017. Geneva: WHO; 2017."},{"issue":"13","key":"key20190820092154_B3","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection","volume":"14","author":"Girardi","year":"2000","unstructured":"3. Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G; Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000;14(13):1985-91.","journal-title":"AIDS."},{"key":"key20190820092154_B4","volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil [Internet]","author":"Brasil. Minist\u00e9rio da Sa\u00fade","year":"2011","unstructured":"4. Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil [Internet]. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2011 [citado 2018 Set 12]. Dispon\u00edvel em: http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_recomendacoes_controle_tuberculose_brasil.pdf"},{"key":"key20190820092154_B5","volume-title":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Adultos vivendo com HIV\/AIDS [Internet]","author":"Brasil. Minist\u00e9rio da Sa\u00fade","year":"2013","unstructured":"5. Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de DST, Aids e Hepatites Virais. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Adultos vivendo com HIV\/AIDS [Internet]. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2013 [citado 2018 Set 12]. Dispon\u00edvel em: http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/protocolo_clinico_manejo_hiv_adultos.pdf"},{"issue":"6","key":"key20190820092154_B6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1473-3099(14)70711-X","article-title":"ANRS 12 180 Reflate TB study group. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial","volume":"14","author":"Grinsztejn","year":"2014","unstructured":"6. Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Ch\u00eane G, Molina JM; ANRS 12 180 Reflate TB study group. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. Lancet Infect Dis. 2014;14(6):459-67. Erratum in: Lancet Infect Dis. 2014;14(6):448.","journal-title":"Lancet Infect Dis."},{"key":"key20190820092154_B7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1741-7015-11-253","article-title":"Management of HIV-associated tuberculosis in resource limited settings: a state of the art review","volume":"11","author":"Lawn","year":"2013","unstructured":"7. Lawn SD, Meintjes G, McIlleron H, Harries AD, Wood R. Management of HIV-associated tuberculosis in resource limited settings: a state of the art review. BMC Med. 2013;11:253. Review.","journal-title":"BMC Med."},{"key":"key20190820092154_B8","volume-title":"Pharmaceutical care practice","author":"Cipolle","year":"1998","unstructured":"8. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998. 359 p."},{"key":"key20190820092154_B9","volume-title":"Pharmaceutical care practice: the clinician's guide","author":"Cipolle","year":"2004","unstructured":"9. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician's guide. 2nd ed. New York: McGraw-Hill; 2004. 394 p.","edition":"2nd ed."},{"issue":"1","key":"key20190820092154_B10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jcpt.12347","article-title":"Medication error with antituberculosis therapy in an inpatient, academic setting: forgotten but not gone","volume":"41","author":"Jen","year":"2016","unstructured":"10. Jen SP, Zucker J, Buczynski P, Odenigbo C, Cennimo D, Patrawalla A. Medication error with antituberculosis therapy in an inpatient, academic setting: forgotten but not gone. J Clin Pharm Ther. 2016;41(1):54-8.","journal-title":"J Clin Pharm Ther."},{"key":"key20190820092154_B11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/TCRM.S118442","article-title":"Pharmaceutical interventions in the management of tuberculosis in a pneumophtisiology department, Ivory Coast","volume":"12","author":"Abrogoua","year":"2016","unstructured":"11. Abrogoua DP, Kamenan BA, Ahui BJ, Doffou E. Pharmaceutical interventions in the management of tuberculosis in a pneumophtisiology department, Ivory Coast. Ther Clin Risk Manag. 2016;12:1749-56.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"key20190820092154_B12","first-page":"269","article-title":"Seguimento Farmacoterap\u00eautico em pacientes em tuberculose pulmonar atrav\u00e9s da metodologia D\u00e1der","volume":"27","author":"Santos","year":"2006","unstructured":"12. Santos AC, Pereira DA, Silva AO, Lopes LC. Seguimento Farmacoterap\u00eautico em pacientes em tuberculose pulmonar atrav\u00e9s da metodologia D\u00e1der. Rev Ci\u00eanc Farm B\u00e1sica Apl. 2006;27(3):269-73.","journal-title":"Rev Ci\u00eanc Farm B\u00e1sica Apl."},{"issue":"10","key":"key20190820092154_B13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/hiv.12375","article-title":"HIV pharmacist's impact on inpatient antiretroviral errors","volume":"17","author":"Liedke","year":"2016","unstructured":"13. Liedke MD, Tomlin CR, Skrepnk GH, Farmer KC, Johnson PN, Rathbun RC. HIV pharmacist's impact on inpatient antiretroviral errors. HIV Med. 2016; 17(10):717-23.","journal-title":"HIV Med."},{"issue":"5","key":"key20190820092154_B14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jsps.2016.11.004","article-title":"HIV pharmaceutical care in primary healthcare: improvement in CD4 count and reduction in drug related problems","volume":"25","author":"Molino","year":"2016","unstructured":"14. Molino CG, Carnevale RC, Rodrigues AT, Moriel P, Mazzola PG. HIV pharmaceutical care in primary healthcare: improvement in CD4 count and reduction in drug related problems. Saudi Pharm J. 2016;25(5):724-33.","journal-title":"Saudi Pharm J."},{"issue":"3","key":"key20190820092154_B15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1590\/S1984-82502009000300026","article-title":"Pharmaceutical care to pregnant women carryng human immunodeficiency virus","volume":"45","author":"Romeu","year":"2010","unstructured":"15. Romeu GA, Paiva LV, Moura F\u00e9 MM. Pharmaceutical care to pregnant women carryng human immunodeficiency virus. Braz J Pharm Sci. 2010;45(3):593-602.","journal-title":"Braz J Pharm Sci."},{"issue":"3","key":"key20190820092154_B16","first-page":"709","article-title":"Terminology, the importance of defining","volume":"38","author":"van Mil","year":"2016","unstructured":"16. van Mil JW, Henman M. Terminology, the importance of defining. Int J Clin Pharm. 2016;38(3):709-13.","journal-title":"Int J Clin Pharm."},{"issue":"2","key":"key20190820092154_B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11096-016-0262-0","article-title":"Medical care and drug related problems: do doctors and pharmacists speak the same language?","volume":"38","author":"Foppe van Mil","year":"2016","unstructured":"17. Foppe van Mil JW, Westerlund T, Brown L, Chen TF, Henman M, Hersberger K, et al. Medical care and drug related problems: do doctors and pharmacists speak the same language? Int J Clin Pharm. 2016;38(2):191-4. Review. Erratum in: Int J Clin Pharm. 2016;38(2):195.","journal-title":"Int J Clin Pharm."},{"issue":"1","key":"key20190820092154_B18","doi-asserted-by":"crossref","first-page":"20714","DOI":"10.7448\/IAS.19.1.20714","article-title":"TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis","volume":"19","author":"Ford","year":"2016","unstructured":"18. Ford N, Matteelli A, Shubber Z, Hermans S, Meintjes G, Grisztejn B, et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19(1):20714. Review.","journal-title":"J Int AIDS Soc."},{"key":"key20190820092154_B19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IJGM.S135305","article-title":"Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia","volume":"10","author":"Teshome Kefale","year":"2017","unstructured":"19. Teshome Kefale A, Anagaw YK. Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia. Int J Gen Med. 2017;10:161-9.","journal-title":"Int J Gen Med."},{"issue":"1","key":"key20190820092154_B20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11096-016-0402-6","article-title":"Ramalho-de-Oliveira D. Impact of medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease","volume":"39","author":"Detoni","year":"2017","unstructured":"20. Detoni KB, Oliveira IV, Nascimento MM, Caux TR, Alves MR, Ramalho-de-Oliveira D. Impact of medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease. Int J Clin Pharm. 2017;39(1):95-103.","journal-title":"Int J Clin Pharm."},{"issue":"3","key":"key20190820092154_B21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.18553\/jmcp.2010.16.3.185","article-title":"Medication therapy management: 10 years of experience in a large integrated health care system","volume":"16","author":"Ramalho de Oliveira","year":"2010","unstructured":"21. Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16(3):185-95.","journal-title":"J Manag Care Pharm."},{"issue":"31","key":"key20190820092154_B22","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.2174\/1381612043382576","article-title":"The impact of pharmaceutical care practice on the practioner and the patient in the ambulatory practice setting: twenty-five years of experience","volume":"10","author":"Strand","year":"2004","unstructured":"22. Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The impact of pharmaceutical care practice on the practioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des. 2004;10(31):3987-4001. Review.","journal-title":"Curr Pharm Des."},{"issue":"5","key":"key20190820092154_B23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/S1806-37132010000500016","article-title":"Drogas antituberculose: intera\u00e7\u00f5es medicamentosas, efeitos adversos e utiliza\u00e7\u00e3o em situa\u00e7\u00f5es especiais. Parte 1: F\u00e1rmacos de primeira linha","volume":"36","author":"Arbex","year":"2010","unstructured":"23. Arbex MA, Varella MC, Siqueira HR, Mello FA. Drogas antituberculose: intera\u00e7\u00f5es medicamentosas, efeitos adversos e utiliza\u00e7\u00e3o em situa\u00e7\u00f5es especiais. Parte 1: F\u00e1rmacos de primeira linha. J Bras Pneumol. 2010;36(5): 626-40.","journal-title":"J Bras Pneumol."},{"key":"key20190820092154_B24","volume-title":"Adherence to long-term therapies: evidence for action [Internet]","author":"World Health Organization (WHO)","year":"2003","unstructured":"24. World Health Organization (WHO). Adherence to long-term therapies: evidence for action [Internet]. Geneva: WHO; 2003 [cited May 6]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/42682\/1\/9241545992.pdf"},{"issue":"4","key":"key20190820092154_B25","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1590\/S0080-62342010000400041","article-title":"Ades\u00e3o ao tratamento por indiv\u00edduos com a coinfec\u00e7\u00e3o HIV\/tuberculose: revis\u00e3o integrativa da literatura","volume":"44","author":"Neves","year":"2010","unstructured":"25. Neves LA, Reis RK, Gir E. Ades\u00e3o ao tratamento por indiv\u00edduos com a coinfec\u00e7\u00e3o HIV\/tuberculose: revis\u00e3o integrativa da literatura. Rev Esc Enferm USP. 2010;44(4):1135-41.","journal-title":"Rev Esc Enferm USP."},{"issue":"2","key":"key20190820092154_B26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0080-62342010000200020","article-title":"Abandono do tratamento de tuberculose em coinfectados TB\/HIV","volume":"44","author":"Rodrigues","year":"2010","unstructured":"26. Rodrigues IL, Monteiro LL, Pacheco RH, Silva SE. Abandono do tratamento de tuberculose em coinfectados TB\/HIV. Rev Esc Enferm USP. 2010;44(2):383-7.","journal-title":"Rev Esc Enferm USP."},{"issue":"3","key":"key20190820092154_B27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.17665\/1676-4285.20165397","article-title":"Social, clinical and adherence factors in patients co-infected with HIV\/tuberculosis: a descriptive study","volume":"15","author":"Dam\u00e1sio","year":"2016","unstructured":"27. Dam\u00e1sio GS, Fran\u00e7a HM, Oliveira IC, Ara\u00fajo AR, Feij\u00e3o AR. Social, clinical and adherence factors in patients co-infected with HIV\/tuberculosis: a descriptive study. Online Braz J Nurs. 2016;15(3):414-22.","journal-title":"Online Braz J Nurs."},{"issue":"11","key":"key20190820092154_B28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1060028013504075","article-title":"Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients","volume":"47","author":"Tseng","year":"2013","unstructured":"28. Tseng A, Szadkowski L, Walmsley S, Salit I, Raboud J. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Ann Pharmacother. 2013;47(11):1429-39.","journal-title":"Ann Pharmacother."},{"issue":"2","key":"key20190820092154_B29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4034\/RBCS.2012.16.02.06","article-title":"Fatores sociodemogr\u00e1ficos e cl\u00ednicos associados \u00e0 TARV e \u00e0 contagem T CD4","volume":"16","author":"Pereira","year":"2012","unstructured":"29. Pereira LB, Albuquerque JR, Santos JM, Lima FL, Saldanha AA. Fatores sociodemogr\u00e1ficos e cl\u00ednicos associados \u00e0 TARV e \u00e0 contagem T CD4. Rev Bras Ci\u00ean Sa\u00fade. 2012;16(2):149-60.","journal-title":"Rev Bras Ci\u00ean Sa\u00fade."},{"key":"key20190820092154_B30","volume-title":"Rea\u00e7\u00f5es adversas a medicamentos","author":"Lee","year":"2009","unstructured":"30. Lee A. Rea\u00e7\u00f5es adversas a medicamentos. Porto Alegre: Artmed; 2009. 488 p."}],"container-title":["Einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T02:20:59Z","timestamp":1610850059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/drug-therapy-problems-for-patients-with-tuberculosis-and-hiv-aids-at-a-reference-hospital\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8,19]]}},"alternative-id":["10.31744\/einstein_journal\/2019AO4696"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2019ao4696","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"eAO4696"}}